Deriving clinically meaningful cut-scores for fatigue in a cohort of breast cancer survivors: A Health, Eating, Activity, and Lifestyle (HEAL) Study

Quality of Life Research

Volumn 22, Issue 9, 2013, Pages 2279-2292

  Stover, Angela M ^a   Reeve, Bryce B ^a   Piper, Barbara F ^b   Alfano, Catherine M ^c   Smith, Ashley Wilder ^c   Mitchell, Sandra A ^c   Bernstein, Leslie ^d   Baumgartner, Kathy B ^e   McTiernan, Anne ^f   Ballard Barbash, Rachel ^c  

^a The University of North Carolina at Chapel Hill   (United States)

^b NATIONAL UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF LOUISVILLE   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Breast cancer survivors; Cancer related fatigue; Health related quality of life; Measurement; Piper Fatigue Scale

Indexed keywords

AGED; ARTICLE; BREAST TUMOR; CLASSIFICATION; COHORT ANALYSIS; FATIGUE; FEMALE; HEALTH STATUS; HUMAN; MIDDLE AGED; PATHOPHYSIOLOGY; QUALITY OF LIFE; REFERENCE VALUE; SURVIVOR;

AGED; BREAST NEOPLASMS; COHORT STUDIES; FATIGUE; FEMALE; HEALTH STATUS; HUMANS; MIDDLE AGED; QUALITY OF LIFE; REFERENCE VALUES; SURVIVORS;

EID: 84892811773     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-013-0360-6     Document Type: Conference Paper

References (60)

1. Meeske, K., Smith, A. W., Alfano, C. M., McGregor, B. A., McTiernan, A., Baumgartner, K. B., et al. (2007). Fatigue in breast cancer survivors two to five years post diagnosis: A HEAL Study report. Quality of Life Research, 16, 947-960.
2. Kim, J.-E., Dodd, M. J., Aouizerat, B. E., Jahan, T., & Miaskowski, C. (2009). A review of the prevalence and impact of multiple symptoms in oncology patients. Journal of Pain and Symptom Management, 37, 715-736.
3. Scott, J. A., Lasch, K., Barsevick, A., & Piault-Louis, E. (2011). Patient-reported outcomes of fatigue consortium (PROOF-C). Patients' experiences with cancer-related fatigue: A systematic review and synthesis of qualitative research. Oncology Nursing Forum, 38, E191-E203.
4. Ganz, P. A., Desmond, K. A., Leedham, B., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2002). Quality of life in longterm, disease-free survivors of breast cancer: A follow-up study. Journal of the National Cancer Institute, 94, 39-49.
5. Mitchell, S. (2010). Cancer-related fatigue: State of the science. Physical Medicine and Rehabilitation, 2, 364-383.
6. Piper, B. F., & Cella, D. (2010). Cancer-related fatigue: definitions and clinical subtypes. Journal of the National Comprehensive Cancer Network, 8, 958-966.
7. Knowles, G., Borthwick, D., McNamara, S., Miller, M., & Leggot, L. (2000). Survey of nurses' assessment of cancer-related fatigue. European Journal of Cancer Care, 9, 105-113.
8. Pachman, D. R., Barton, D. L., Swetz, K. M., & Loprinzi, C. L. (2012). Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. Journal of Clinical Oncology, 30, 3687-3696.
9. Barsevick, A. M., & Cleeland, C. S. (2010). ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. Journal of Pain and Symptom Management, 39, 1086-1099.
10. The Cancer-Related Fatigue Guidelines (Version 4.2007) in The Complete Library of NCCN Clinical Practice Guidelines in Oncology [CD-ROM] Jenkintown, Pennsylvania: © 2006 National Comprehensive Cancer Network, Inc.; Mar, 2008. To view the most recent and complete version of the guideline, go to www.nccn.org.
11. Berger, A. M., Abernethy, A. P., & Atkinson, A. (2010). Cancerrelated fatigue. JNCCN, 8, 904-931.
12. Mitchell, S. A., Beck, S. L., & Eaton, L. H. (2009). ONS putting evidence into practice (PEP): fatigue. In L. H. Eaton & J. M. Tipton (Eds.), Putting evidence into practice. Pittsburgh: Oncology Nursing Society.
13. Cella, D., Davis, K., Breitbart, W., Curt, G., for the Fatigue Coalition. (2001). Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. Journal of Clinical Oncology, 19, 3385-3391.
14. Cella, D., Peterman, A., Passik, S., et al. (1998). Progress towards guidelines for the management of fatigue. Oncology, 12, 369-377.
15. Vogelzang, N., Breitbart, W., Cella, D., et al. (1997). Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tri-part assessment survey. Seminars in Hematology, 34(Supplement 2), 4-12.
16. Agasi-Idenburg, C., Velthuis, M., & Wittink, H. (2010). Quality criteria and user-friendliness in self-reported questionnaires on cancer-related fatigue: A review. Journal of Clinical Epidemiology, 63, 705-711.
17. Dittner, A. J., Wessely, S. C., & Brown, R. G. (2004). The assessment of fatigue: A practical guide for clinicians and researchers. Journal of Psychosomatic Research, 56, 157-170.
18. Jean-Pierre, P., & Figueroa-Moseley, C. D. (2007). Assessment of cancer-related fatigue: Implications for clinical diagnosis and treatment. Oncologist, 12(Supplement 1), 11-21.
19. Minton, O., & Stone, P. (2009). A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Annals of Oncology, 20, 17-25.
20. Mota, D. D., & Pimenta, C. A. (2006). Self-report instruments for fatigue assessment: A systematic review. Research and Theory for Nursing Practice, 20, 49-78.
21. Whitehead, L. (2009). The measurement of fatigue in chronic illness: Asystematic review of unidimensional and multidimensional fatigue measures. Journal of Pain and Symptom Management, 37, 107-128.
22. Mendoza, T., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. K., et al. (1999). The rapid assessment of fatigue severity in cancer patients: Use of the brief fatigue inventory. Cancer, 85, 1186-1196.
23. Borneman, T., Koczywas,M., Sun, V. C., Piper, B. F., Uman, G., & Ferrell, B. (2010). Reducing patient barriers to pain and fatigue management. Journal of Pain and Symptom Management, 39, 486-501.
24. Weilgus, K., Berger, A. M., & Hertzog, M. (2009). Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer. Oncology Nursing Forum, 36, 38-48.
25. Cullum, J. L., Wojciechowski, A. E., & Simpson, J. S. A. (2004). Bupropion sustained release treatment reduces fatigue in cancer patients. Canadian Journal of Psychiatry, 49, 139-144.
26. Cooper, M. R., Bird, H. M., & Steinberg, M. (2009). Efficacy and safety of modafinil in the treatment of cancer-related fatigue. The Annals of Pharmacotherapy, 43, 721-725.
27. Jean-Pierre, P., Morrow, G. R., Roscoe, J. A., Heckler, C., Mohile, S., Janelsins, M., et al. (2010). A phase 3 randomized, placebo-controlled, doubleblind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: A University of Rochester cancer center community clinical oncology program research base study. Cancer, 116, 3513-3520.
28. Moss, E. L., Simpson, J. S., Pelletier, G., et al. (2006). An openlabel study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners. Psycho-oncology, 15, 259-267.
29. Nering, M. L., & Ostini, R. (Eds.). (2010). Handbook of polytomous item response theory models. New York, NY: Routledge.
30. Chamberlain Wilmoth, M., Coleman, E. A., Smith, S. C., & Davis, C. (2004). Fatigue, weight gain, and altered sexuality in patients with breast cancer: Exploration of a symptom cluster. Oncology Nursing Forum, 31, 1069-1075.
31. Webber, K., Mok, K., Bennett, B., Lloyd, A. R., Friedlander, M., Juraskova, I., et al. (2011). If I am in the mood, I enjoy it: An exploration of cancer-related fatigue and sexual functioning in women with breast cancer. The Oncologist, 16, 1333-1344.
32. Ganz, P. A., Rowland, J. H., Desmond, K., Meyerowitz, B. E., & Wyatt, G. E. (1998). Life after breast cancer: understanding women's health-related quality of life and sexual functioning. Journal of Clinical Oncology, 16, 501-514.
33. Ganz, P. A., Desmond, K. A., Belin, T. R., Meyerowitz, B. E., & Rowland, J. H. (1999). Predictors of sexual health in women after a breast cancer diagnosis. Journal of Clinical Oncology, 17, 2371-2380.
34. Fobair, P., & Spiegel, D. (2010). Concerns about sexuality after breast cancer. In V. T. Devita, T. S. Lawrence, & S. A. Rosenberg (Eds.), Cancer principles and practice of oncology: Annual advances in oncology (pp. 7-14). Philadelphia, PA: Lippincott Williams & Wilkins.
35. Lindau, S. T., Schumm, L. P., Laumann, E. O., Levinson, W., O'Muircheartaigh, C. A., & Waite, L. J. (2007). A study of sexuality and health among older adults in the United States. New England Journal of Medicine, 357, 762-774.
36. Rubin, P. (2001). Clinical oncology: A multidisciplinary approach for physicians and students (8th ed.). Philadelphia: W. B. Saunders Company.
37. Piper, B. F., Dibble, S. L., Dodd, M. J., Weiss, M. C., Slaughter, R. E., & Paul, S. M. (1998). The revised piper fatigue scale: Psychometric evaluation in women with breast cancer. Oncology Nursing Forum, 25, 677-684.
38. Reeve, B. B., Stover, A. M., Alfano, C. M., Piper, B. F., Bernstein, L., Baumgartner, K., et al. (2012). Psychometric evaluation and reduction of the piper fatigue scale based on a cohort of breast cancer survivors. Breast Cancer Research and Treatment, 136, 9-20.
39. McTiernan, A., Rajan, K. B., Tworoger, S. S., Irwin, M., Bernstein, L., Baumgartner, R., et al. (2003). Adiposity and sex hormones in postmenopausal breast cancer survivors. Journal of Clinical Oncology, 21, 1961-1966.
40. Groenvold, M., Aagard Petersen, M., Idler, E., Bjorner, J. B., Fayers, P. M., & Mouridsen, H. T. (2007). Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Research and Treatment, 105, 209-219.
41. Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item shortform health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473-483.
42. Schag, C. A. C., Heinrich, R. L., Aadland, R. L., & Ganz, P. A. (1990). Assessing problems of cancer patients: Psychometric properties of the Cancer Inventory of Problem Situations (CIPS). Health Psychology, 9, 83-102.
43. Bjorner, J. B., Wallenstein, G. V., Martin, M. C., Lin, P., Piech Blaisdell-Gross, C. T., et al. (2007). Interpreting score differences in the SF-36 Vitality scale: Using clinical conditions and functional outcomes to define the minimally important difference. Current Medical Research and Opinions, 23, 731-739.
44. Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Medical Care, 41, 582-592.
45. Revicki, D., Hays, R., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology, 61, 102-109.
46. Sloan, J., Cella, D., & Hays, R. (2005). Clinical significance of patient-reported questionnaire data: Another step toward consensus. Journal of Clinical Epidemiology, 58, 1217-1219.
47. Schwartz, A. L., Meek, P. M., Nail, L., Fargo, J., Lundquist, M., Donofrio, M., et al. (2002). Measurement of fatigue: determining minimally important differences. Journal of Clinical Epidemiology, 55, 239-244.
48. American Joint Committee on Cancer. (2010). AJCC cancer staging handbook (7th ed.). Chicago: Author.
49. Hand, D. J., & Taylor, C. C. (1987). Multivariate analysis of variance and repeated measures. London: Chapman and Hall.
50. Davies, N., Gibbons, E., Mackintosh, A., Fitzpatrick, R. On behalf of the Oxford Patient-Reported Outcomes Measurement Group (2009). A structured review of patient-reported outcome measures (PROMs) for women with breast cancer. Oxford: University of Oxford.
51. Wilson, R. W., Hutson, L. M., & VanStry, D. (2005). Comparison of 2 quality-of-life questionnaires in women treated for breast cancer: The RAND 36-Item health survey and the functional living index-cancer. Physical Therapy, 85, 851-860.
52. Bower, J. E., Ganz, P. A., Desmond, K. A., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000). Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. Journal of Clinical Oncology, 18, 743-749.
53. Merle, M. E. (1998). Correlates of fatigue in survivors of breast cancer. Cancer Nursing, 21, 136-142.
54. Haghighat, S., Esmail Akbari, M., Holakouei, K., Rahimi, A., & Montazeri, A. (2003). Factors predicting fatigue in breast cancer patients. Supportive Care in Cancer, 11, 533-538.
55. Day, R., Ganz, P. A., Costantino, J. P., Cronin, W. M., Wickerman, D. L., & Fisher, B. (1999). Health-related quality of life and tamoxifen in breast cancer prevention: A report from the national surgical adjuvant breast and bowel project P-1 study. Journal of Clinical Oncology, 17, 2659-2669.
56. de Jong, N., Courtens, A. M., Abu-Saad, H. H., & Schouten, H. C. (2002). Fatigue in patients with breast cancer receiving adjuvant chemotherapy: A review of the literature. Cancer Nursing, 25, 283-297.
57. Lin, N. U., Vanderplas, A., Hughes, M. E., Theriault, R. L., Edge, S. B., Wong, Y.-N., et al. (2012). Clinicopathologic features, patterns of recurrence, and survival among women with triplenegative breast cancer in the national comprehensive cancer network. Cancer, 118, 5463-5472.
58. Rakka, E. A., El-Sayed, M. E., Green, A. R., Lee, A. H. S., Robertson, J. F., & Ellis, I. O. (2007). Prognostic markers in triple-negative breast cancer. Cancer, 109, 25-32.
59. Anderson, W. F., Chu, K. C., Chatterjee, N., Brawley, O., & Brinton, L. A. (2001). Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. Journal of Clinical Oncology, 19, 18-27.
60. Pilkonis, P. A., Choi, S. W., Reise, S. P., Stover, A. M., Riley, W.T., & Cella, D. (2011). Item banks for measuring emotional distress from the patient-reported outcomes measurement information system (PROMIS): Depression, anxiety, & anger. Assessment, 18, 263-283.